the402 x402 endpoint directory

Brahmer 2018 ASCO Table 4.4 irAE diabetes from glucose_mg_dl (50-1000, mg/dL only) plus caller ketosis, t1dm, severe_u

Mazzaferro 2009 Up-to-seven: meets_up_to_seven is true iff tumor_count plus largest_cm is 7 or less and microvascular_

ASCO 2018 (Brahmer) irAE nephritis grade from creatinine vs baseline (mg/dL). First-match: 4 if dialysis or life-threa

NCI CTC v2.0 Mucositis due to radiation (Trotti 2000). none → 0; erythema → 1; patchy_pseudomembrane (≤1.5 cm, noncont

Brahmer 2018 ASCO Table 2.1 irAE colitis grade from stools_over_baseline (0-40) and four caller-assigned flags. First-

Mazzaferro 2018 Metroticket 2.0 AFP-adjusted-to-HCC-size 70% 5-year HCC-specific survival criteria. meets_70pct_hcc_sp

Brahmer 2018 ASCO Table 3.1 irAE pneumonitis. First-match: G4 life-threatening respiratory compromise; else G3 hospita

Grossman 2018 Eat, Sleep, Console functional assessment. well_managed iff eat ≥1 oz per feed or breastfeed well, sleep

ICC 2022 prefibrotic and overt PMF (Arber 2022). Diagnosed iff 3 majors and ≥1 minor. Majors: megakaryocyte morphology

Lencioni 2010 mRECIST for typical intrahepatic HCC target lesions. First-match: PD if new_lesion or a 20% or greater v

Ridker JAMA 2007 Reynolds Risk Score, women Model B only: 10-year CVD percent from age, SBP, hsCRP, total cholesterol,

MacMahon 2017 Fleischner table for one solid noncalcified incidental nodule. size_mm 1-30 and caller-assigned high_ris

Kumar 2016 IMWG measurable serum+urine M-protein response. First-match PD, sCR, CR, VGPR, PR, MR, or SD from caller-as

ICC 2022 systemic mastocytosis (Arber 2022). Met when major infiltrates (≥15 tryptase- and/or CD117-positive MCs in ag

2017 McDonald typical CIS (Thompson 2018). mcdonald_ms iff typical_cis and no_better_explanation and: ≥2 attacks with

2023 Duke-ISCVID (Fowler) IE criteria. Definite if pathologic_definite or clinical_definite (2 major, or 1 major plus

High-dose insulin euglycemia therapy (HIET) from Engebretsen 2011: 1 U/kg insulin bolus, then a 1-10 U/kg/h continuous

Jawhar 2019 mutation-adjusted risk score (MARS) for advanced systemic mastocytosis: age >60 (1), hemoglobin <10 g/dL (

Wolf 2024 REST-LGS: four major criteria (+3 each) and four minor (+1 each). Max 16. likely if score > 11, possible if

Reig 2022 BCLC stage 0/A/B/C/D from caller-assigned cancer-related ECOG, preserved liver function, transplant option,

ARDS Network 2000 predicted body weight (PBW) from height and sex, and the lower-tidal-volume arm 6 mL/kg PBW. Male PB

Kaplan 1990 estimated plasma volume for therapeutic plasma exchange: epv_l = 0.065 * weight_kg * (1 - hematocrit_perce

Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uni

Extermann 2012 CRASH chemotherapy toxicity score (not trauma CRASH): diastolic BP, IADL, LDH versus ULN, caller-assign

Hurria 2011 Table 5 CARG toxicity: age ≥72 (+2), GI/GU (+2, not inverted), standard dose (+2), polychemotherapy (+2),

Goodacre 2021 PRIEST: NEWS2 Chart 1 Scale 1 vitals (RR, SpO2 Scale 1 only, oxygen +2, temperature, SBP, HR) + alertnes

Adult levothyroxine (LT4) full-replacement estimate: daily_lt4_mcg = weight_kg * 1.6 (ATA 2014). Weight in kg or lb. N

Sperduto 2019 updated GI-GPA: KPS <80 = 0, 80 = 1.0, 90-100 = 2.0; age >=60 = 0, <60 = 0.5; extracranial metastases pr

Terrapon 2021 Therapy-Disability-Neurology (TDN) grade. Caller assigns therapy t1-t5, modified Rankin 0-6 (6 is death)

Wolfe 2005 Patient Activity Scale II (PAS-II): (haq_ii * 3.33 + pain_vas + patient_global_vas) / 3. HAQ-II 0-3 (not HA

Saisho 2011 CPR index: serum C-peptide (ng/mL) / plasma glucose (mg/dL) * 100, two decimals. timing fasting or postpra

Farris 2017 brain metastasis velocity: bmv = new_brain_metastases / years_since_first_srs, 1 decimal. new_brain_metast

Hevesi 2018 hip RAPID: sex (female 0, male 1) + Tonnis 0/1/2 (0, 2, 3 points; grade 3 invalid) + caller-assigned cam (

Bastion classification of lower-limb IED injury (Jacobs 2014). Caller assigns class 1-5 as the most proximal extent. R

CDC/HICPAC surgical wound classification Class I-IV as assigned by the caller (Mangram 1999 Table 7). Returns wound_cl

Verheyden 2004 original Trunk Impairment Scale from caller-assigned static sitting balance 0-7, dynamic sitting balanc

Schönenberger 2016 SETscore: 15 caller-assigned flags (neurological function, lesion, organ function/procedure). Weigh

Fredriksson 1978 PASI from four regions. Each region: area 0-6 and erythema, induration, and scaling 0-4. Region score

Olmos 2017 RISK-E (Risk-Endocarditis) for in-hospital mortality after cardiac surgery in active left-sided IE. Age <=5

Ho 2004 day-3 IV-steroid score for severe UC (0–9): mean stools (<4 → 0; 4 ≤ x < 6 → 1; 6 ≤ x ≤ 9 → 2; x > 9 → 4), cal

Heide 2001 SCORMA: extent_percent/5 + 5*intensity_sum + 2*symptom_sum/5. Extent 0-100 (diffuse cutaneous mastocytosis

McEntire 2025 FACE DROPS: seven caller-assigned flags for acute Lyme disease-associated facial palsy versus Bell palsy

Hyams 2016 Rome IV H1b. Functional nausea iff 2-month duration plus bothersome_nausea_twice_weekly_not_meal_related, n

Stanghellini 2016 Rome IV belching disorders (B2). rome_iv_belching is true iff bothersome (severe enough to impact us

Richards 1990 BUN/creatinine ratio as bun_mg_dl / creatinine_mg_dl, rounded to one decimal. A ratio of 36 or greater s

Rodeghiero 2010 ISTH/SSC bleeding assessment tool (BAT). Fourteen caller-assigned Table S1 symptom integers (0-4; cns_

Black 2001 FRACTURE Index with known total-hip T-score. Age <65 0 through >=85 5. T >= -1 0; -2 <= T < -1 2; -2.5 <= T

Sitzman 2011 Wisconsin Criteria. Meets criteria if any one of five caller-assigned findings is true: bony step-off or

Adult maximum normal erythrocyte sedimentation rate (mm/h, 98th percentile approximation) from age and sex (Miller 198

Qureshi 1998 pediatric asthma score: five caller-assigned 1-3 domains — respiratory_rate (Table 1 age-banded ordinal,